Pharma Equity Group A/S (CPH:PEG)
Denmark
· Delayed Price · Currency is DKK 0.150
-0.001 (-0.33%)
Feb 21, 2025, 2:55 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 184.13 million as of February 21, 2025. Its market cap has decreased by -48.28% in one year.
Market Cap
184.13M
Enterprise Value
227.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 184.13M, a decrease of -76.00%. That is a compound annual growth rate of -52.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 184.13M | -21.05% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 2,642.57B |
| Coloplast | 179.23B |
| Genmab | 100.87B |
| Demant | 57.17B |
| Zealand Pharma | 53.27B |
| H. Lundbeck | 37.77B |
| Ambu A/S | 37.73B |
| ALK-Abelló | 36.16B |